Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Vinod P. Shah, K.K. Midha, S Dighe et al. · European Journal of Drug Metabolism and Pharmacokinetics · 1991 · 617 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +14

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.

Parkash S. Gill, Byron M. Espina, Franco M. Muggia et al. · Journal of Clinical Oncology · 1995 · 242 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells

Tatsuhiro Ishida, Marc Kirchmeier, Elaine H. Moase et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2001 · 211 citations

Pharmacy, Oncology, Pharmaceutics +14

Daunoxome® Treatment of Solid Tumors: Preclinical and Clinical Investigations

Eric A. Forssen, Michael E. Ross · Journal of Liposome Research · 1994 · 118 citations

Pharmacy, Oncology, Pharmacology +17

Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue.

Eric A. Forssen, R Malé-Brune, Jill Adler‐Moore et al. · PubMed · 1996 · 105 citations · Full text

Medicine, Oncology, Pharmacology +17